All News

People are looking--and judging.

Retail pharmacies are in the news a lot these days. Unfortunately, it is not the kind of news anyone wants to hear.

As bacterial meningitis spikes in certain regions of the U.S. and with more schools recommending vaccination, some pharmacy chains are helping to combat the disease.

Physicians and pharmacists welcomed FDA’s recent approval of etanercept-szzs (Erelzi), a biosimilar to Amgen’s top-selling Enbrel for rheumatoid arthritis, plaque psoriasis, and other inflammatory conditions.

FDA’s method for naming biosimilars and interchangeable biologics came under fire long before the first biosimilar, Zarxio, was approved last spring.

Why are Rx drugs so expensive? No one seems to have a good answer.

Researchers reported that nearly half of cigarette smokers, as well as nearly half of tobacco users who don’t smoke cigarettes, support such a policy.

Both brick-and-mortar and mail-order pharmacies receive high scores when it comes to customer satisfaction, according to J.D. Power’s 2016 U.S. Pharmacy Study.

New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.

New branded drugs, new generics.

Dennis Song, RPh, describes the steps to take when starting a compounding services business.

Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.

Anxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh.

The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.

Despite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.

A coordinated effort needs to be made to preserve the health and safety of life on earth.

Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.

Generic drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them.

What do pharmacists and teachers - and an awful lot of other people - have in common?

Biosimilars are the future of pharmacy. When they hit community pharmacy, issues that have been important in specialty settings are going to explode.

McKesson recognized some outstanding community pharmacies at this year's IdeaShare.

Pharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.

Anticoagulation briefs.

Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.

What is the pharmacist’s duty? This case history may shed some light.

FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.

Once physicians see what you can do for them, they won't want to let you go.